The forecasted sales of modulators of the genital system and sex hormones in Germany remain constant from 2024 to 2028, representing 0.8% of total sales each year. Compared to previous years, this stability denotes a lack of growth or decline, suggesting consistent demand or pricing strategies. The compound annual growth rate (CAGR) is flat, indicating no growth momentum in the forecast period.

Future trends to watch for in this market include:

Potential regulatory changes impacting product availability or pricing.
Evolving consumer preferences influenced by innovations in healthcare and wellness.
Demographic shifts affecting the target population for these products.